5-(Methylsulfanyl)pyridin-3-amine dihydrochloride

Catalog No.: 
ACHZLU480
CAS No.: 
1909308-80-0
Molecular Formula: 
C6H10Cl2N2S
Molecular Weight: 
213.13
5-(Methylsulfanyl)pyridin-3-amine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$326.00InquiryInquiry
100mg95%$478.00InquiryInquiry
250mg95%$677.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Methylsulfanyl)pyridin-3-amine dihydrochloride
IUPAC Name5-(methylthio)pyridin-3-amine dihydrochloride
MDL No.-
Molecular FormulaC6H10Cl2N2S
Molecular Weight213.13
SMILESNC1=CC(SC)=CN=C1.[H]Cl.[H]Cl
InChI KeyPCEZYSZXAPHCJH-UHFFFAOYSA-N
Synonym5-(methylsulfanyl)pyridin-3-amine dihydrochloride
CAS No.1909308-80-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHZLU480 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXOVE578 route compound structure diagram
    ACXOVE57813535-01-8In Stock
  4. Then
  5. ACHZLU480 route product structure diagram
    ACHZLU4801909308-80-0
Inquiry

2. ACHZLU480 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPZIE972 route compound structure diagram
    ACPZIE9721881296-22-5In Stock
  2. Then
  3. ACHZLU480 route product structure diagram
    ACHZLU4801909308-80-0
Inquiry

3. ACHZLU480 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXOVE578 route compound structure diagram
    ACXOVE57813535-01-8In Stock
  4. Then
  5. ACHZLU480 route product structure diagram
    ACHZLU4801909308-80-0
Inquiry

Comments (0)